Due to the merger the customers will be benefit from the broader offerings of products that are complementary and capabilities from the leading players in the Life Science industry. Louis, Billerica, MO and MA to the growing markets of Asia. The acquisition was made by the Merck group to creat synergy between the two companies and expanding the customer base of Merck Millipore’s into North American Markets like St. By this time the company was operating in 125 countries with subsidiaries Canada, Germany, Japan, UK. By 1979 the company claimed a market share of 30-40% in the $100 million market with sales increasing annually by 15%. This company is a result of a merger that took place in 1975 between Sigma Chemicals Company and Aldrich Chemical company who were in the business of manufacturing bio chemicals and organic chemicals. As of now the Merck is a globally present brand and has more than 50,000 employees working in 66 countries. Hans Joachim Langmann retired as the chairman of the executive board. The company was handled last by the Merck family in 2000 when, Professor Dr. Among other milestones, one was when the company was publically listed in 1995. Merck is a 350-year-old company founded all the way back in 1668 by Friedrick Jacob Merk making it the oldest pharma and chemical company in the world. Combining the resources, they are serving more 300,000 products with a set of ongoing brands and a supply chain. In the September of 2014, MERCK & SIGMA-ALDRICH announced that they have agreed to enter into a binding agreement, under which Merck will be acquiring the later for $17 billion and forming one of the dominant players in the $130 billion global life science industry. By the year 2024, prescription drug sales worldwide are projected to have a compound annual growth rate of 6.9%, with sales expected to breach trillion-dollar market gap by $180 billon to a staggering $1.18 trillion. To prepare for the future and remain relevant in the ever-evolving business landscape, biopharma and medtech organizations will be looking for new ways to create value and new metrics to make sense of today’s wealth of data. The life sciences sector is at an inflection point.
0 Comments
Leave a Reply. |